Arshed Quyyumi, M.D.'s picture
Quyyumi, M.D.
Professor of Medicine, Division of Cardiology

Emory University School of Medicine


Dr. Arshed A. Quyyumi has been involved in clinical translational research in cardiovascular diseases for over 25 years.  Dr. Quyyumi received his undergraduate degree in Pharmacology and medical degree from the University of London, England. He completed his residency at Guy's and Royal Free Hospitals in London, and cardiology fellowships at National Heart Hospital, London; Massachusetts General Hospital, Boston; and the National Institutes of Health.  After completion of his residency and fellowship, he served in several capacities in the Cardiology Branch of National Heart Lung and Blood Institute, NIH in Bethesda, MD, including Senior Investigator and Director of the Cardiac Catheterization Laboratory.  In 2001 he was appointed Professor of Medicine in the Division of Cardiology at Emory University School of Medicine, and in 2010 he was named Co-Director of the Emory Clinical Cardiovascular Research Institute (ECCRI).  Since 2005, Dr. Quyyumi has been awarded more than $21 million in research funding.  He serves on the Editorial Boards of several national journals, is a member on several Scientific Advisory Boards, and is a reviewer for the NIH-NHLBI Study Sections.  Dr. Quyyumi has authored more than 360 peer-reviewed publications and has been an invited speaker and session chair at numerous National and International scientific meetings and conferences.


Title of Abstract

Circulating Progenitor Cells – Markers of Regenerative Capacity

Research Interests

Dr. Quyyumi's research focus includes vascular biology, angiogenesis, progenitor cell biology, mechanisms of myocardial ischemia, and the role of genetic and environmental risks on vascular disease.  Other interests have spanned the fields of personalized medicine and disparities in cardiovascular diseases.  During his academic career, Dr. Quyyumi has carried out more than 50 NIH, industry-funded, or investigator-initiated projects, including numerous clinical trials.